Keyphrases
Confidence Interval
100%
Intensive Care Unit
79%
ICU Patients
59%
Stress Ulcer Prophylaxis
56%
Denmark
48%
Randomized Clinical Trial
45%
Septic Shock
45%
Disturbed Sleep
45%
Gastrointestinal Bleeding
43%
Ultrasound
43%
Multi-cohort Studies
41%
Workplace Bullying
41%
Randomized Controlled Trial
41%
Long-term Sickness Absence
40%
Odds Ratio
36%
Body Mass Index
35%
Alcohol Consumption
34%
Mediation Analysis
33%
Triage
33%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
33%
National Cohort Study
33%
High Risk
32%
Emergency Department
31%
Copenhagen
30%
Risk Factors
30%
Statistical Analysis Plan
29%
Job Strain
28%
Social Inequality
27%
Prospective Cohort Study
27%
Natural Indirect Effect
26%
Informal Care
26%
Sickness Absence
25%
Clinically Significant
25%
Protocol Analysis
25%
Cause-specific Mortality
24%
Tourette Syndrome
24%
Severe Sepsis
24%
Risk Stratification
24%
Placebo
24%
Hazard Ratio
24%
Cardiopulmonary Bypass
23%
Vector Velocity
23%
Mediating Effect
22%
Pantoprazole
22%
Randomized Trial
22%
Mean Arterial Pressure
22%
Renal Replacement Therapy
22%
Natural Direct Effect
21%
Vector Flow Imaging
21%
Hydroxyethyl Starch
21%
Medicine and Dentistry
Cohort Analysis
78%
Intensive Care Unit
59%
Septic Shock
44%
Randomized Clinical Trial
43%
Stress Ulcer
39%
Hazard Ratio
34%
Randomized Controlled Trial
33%
Gastrointestinal Bleeding
31%
Body Mass Index
31%
Renal Replacement Therapy
29%
Diseases
29%
Flow Imaging
28%
Alcohol Consumption
26%
Emergency Department
24%
Heart Surgery
24%
Mental Health
24%
Breast Cancer
24%
Urokinase Receptor
22%
Clinical Trial
22%
Placebo
22%
Bleeding
20%
Major Depressive Episode
19%
Observational Study
18%
Adolescence
17%
End Stage Renal Disease
17%
Health Behavior
16%
Myeloproliferative Neoplasm
16%
Invasive Procedure
16%
Adiponectin
16%
Systemic Lupus Erythematosus
16%
Sepsis
16%
Stenosis
16%
Acute Coronary Syndrome
16%
Nutrition
16%
Cardiopulmonary Bypass
16%
Soft Tissue Infection
16%
Immunoglobulin G
16%
Leptin
16%
Human immunodeficiency virus
16%
Risk Stratification
16%
Prostate Cancer
16%
Cognitive Therapy
16%
First Trimester Pregnancy
16%
Adverse Event
15%
